scholarly article | Q13442814 |
P50 | author | Fiona Jane Culley | Q59315829 |
P2093 | author name string | Laura Lambert | |
P2860 | cites work | Risks of Antibiotic Exposures Early in Life on the Developing Microbiome | Q21131324 |
Human gut microbiome viewed across age and geography | Q24602950 | ||
Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 | ||
The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection | Q27011872 | ||
Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection | Q27334724 | ||
Respiratory epithelial cells orchestrate pulmonary innate immunity | Q27687743 | ||
Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities | Q28078911 | ||
Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes | Q28241147 | ||
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 | ||
Global burden of childhood pneumonia and diarrhoea | Q28288886 | ||
Environmental exposure to endotoxin and its relation to asthma in school-age children | Q29614294 | ||
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 | ||
Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection. | Q30361458 | ||
In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo | Q30512964 | ||
Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection | Q31144301 | ||
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology | Q33591243 | ||
Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells | Q33770015 | ||
Surfactant protein-A enhances respiratory syncytial virus clearance in vivo | Q33848860 | ||
Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation | Q33936180 | ||
Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. | Q33941032 | ||
Developmental airway cell biology. The "normal" young child | Q33996631 | ||
Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. | Q34059301 | ||
Selective Toll--like receptor expression in human fetal lung | Q34257113 | ||
IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe RSV bronchiolitis: a multicenter cohort study | Q34264474 | ||
Immunity to RSV in Early-Life. | Q34264615 | ||
Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. | Q34439778 | ||
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children | Q34537196 | ||
Neonatal mucosal immunology | Q34540798 | ||
The microbiota of the respiratory tract: gatekeeper to respiratory health | Q34553608 | ||
The burden of respiratory syncytial virus infection in young children | Q34938343 | ||
The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. | Q34983753 | ||
Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium. | Q40480803 | ||
Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis | Q40749296 | ||
Differential cytology of bronchoalveolar lavage fluid in normal children | Q41017864 | ||
Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children | Q41695390 | ||
Production of interferon in respiratory syncytial virus bronchiolitis | Q41790308 | ||
Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection | Q42133926 | ||
Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. | Q42468030 | ||
Diminished actin polymerization by neutrophils from newborn infants | Q42509936 | ||
Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells | Q43673953 | ||
Neonatal respiratory syncytial virus infection | Q44267961 | ||
Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF. | Q45354623 | ||
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. | Q45496193 | ||
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. | Q45556830 | ||
Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy | Q45729843 | ||
Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis | Q45731587 | ||
Leucocyte populations in respiratory syncytial virus-induced bronchiolitis | Q45737596 | ||
The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys | Q46509772 | ||
Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. | Q47847169 | ||
Expression and activity of beta-defensins and LL-37 in the developing human lung | Q47862114 | ||
Foxa2 regulates alveolarization and goblet cell hyperplasia | Q48023667 | ||
Alveolar macrophage immaturity in infants and young children. | Q50515150 | ||
Lymphocyte subsets in bronchoalveolar lavage fluid of children without bronchopulmonary disease | Q51600196 | ||
Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. | Q51721609 | ||
Early life origins of chronic obstructive pulmonary disease. | Q51795710 | ||
Toll-like receptor signaling inhibits structural development of the distal fetal mouse lung. | Q52052465 | ||
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life. | Q52780418 | ||
Role of bronchoalveolar lavage in children with lung disease. | Q54001864 | ||
Effects of endotoxin in the lungs of neonatal rats: age-dependent impairment of the inflammatory response. | Q54620453 | ||
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. | Q55053023 | ||
Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children | Q57011340 | ||
Immune cell profile in infants’ lung tissue | Q59737807 | ||
Alveolar macrophages in perinatal infants. | Q64975721 | ||
Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung | Q68123541 | ||
Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac-1 (CD11b/CD18)-dependent adherence reactions | Q68164281 | ||
Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals | Q71746719 | ||
Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? | Q72205109 | ||
IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis | Q72999006 | ||
Role of alveolar macrophages in innate immunity in neonates: evidence for selective lipopolysaccharide binding protein production by rat neonatal alveolar macrophages | Q73149700 | ||
Delayed inflammatory response to Pneumocystis carinii infection in neonatal mice is due to an inadequate lung environment | Q73209340 | ||
Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice | Q73337354 | ||
Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia | Q73785444 | ||
Neonatal adaptive immunity comes of age | Q80270958 | ||
Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue | Q83168364 | ||
Challenges in infant immunity: implications for responses to infection and vaccines | Q83412177 | ||
Dysregulation of allergic airway inflammation in the absence of microbial colonization | Q83797978 | ||
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation | Q95421092 | ||
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates | Q35002443 | ||
TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization | Q35056722 | ||
Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants | Q35070461 | ||
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency | Q35090141 | ||
Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response | Q35097110 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
NF-κB signaling in fetal lung macrophages disrupts airway morphogenesis | Q35175565 | ||
Immune response to intrapharyngeal LPS in neonatal and juvenile mice | Q35207716 | ||
Intersections between pulmonary development and disease | Q35219746 | ||
Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. | Q35274231 | ||
Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults | Q35521922 | ||
Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice | Q35586896 | ||
Reduced inflammation and altered innate response in neonates during paramyxoviral infection | Q35766500 | ||
Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2. | Q35782203 | ||
Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. | Q35810246 | ||
IL-1beta disrupts postnatal lung morphogenesis in the mouse | Q35855262 | ||
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells | Q35886054 | ||
Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice | Q35913684 | ||
Lung organogenesis | Q35922155 | ||
Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33 | Q35947796 | ||
Neonatal innate TLR-mediated responses are distinct from those of adults. | Q36015806 | ||
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice | Q36050542 | ||
Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation | Q36192895 | ||
Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection | Q36211108 | ||
Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection | Q36276582 | ||
Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis | Q36291211 | ||
Lung Homeostasis: Influence of Age, Microbes, and the Immune System | Q36351058 | ||
Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues | Q36436829 | ||
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly | Q36511529 | ||
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans | Q36650606 | ||
M2 macrophage polarisation is associated with alveolar formation during postnatal lung development | Q36767465 | ||
Innate immunity of the newborn: basic mechanisms and clinical correlates | Q36800979 | ||
Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma | Q36810987 | ||
Airway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection. | Q37088332 | ||
Prenatal inflammation and lung development | Q37121026 | ||
Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities | Q37127882 | ||
The origins of asthma and chronic obstructive pulmonary disease in early life | Q37180202 | ||
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. | Q37194936 | ||
B-cell responses to vaccination at the extremes of age. | Q37400606 | ||
Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice | Q37452318 | ||
Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells | Q37455579 | ||
Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation | Q37582861 | ||
Innate immune response to LPS in airway epithelium is dependent on chronological age and antecedent exposures | Q37596419 | ||
Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation | Q37596502 | ||
Early origins of chronic obstructive pulmonary disease | Q37977748 | ||
The impact of differential antiviral immunity in children and adults | Q38037339 | ||
Respiratory syncytial virus interaction with human airway epithelium | Q38092451 | ||
Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections | Q38095347 | ||
Alveolar macrophages: plasticity in a tissue-specific context | Q38180346 | ||
Viral Bronchiolitis in Children | Q38688225 | ||
Vaccination in early life: standing up to the challenges | Q38814750 | ||
Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103(+) dendritic cell populations following respiratory infection | Q38853730 | ||
Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection | Q38971101 | ||
Childhood Lung Function Predicts Adult Chronic Obstructive Pulmonary Disease and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | Q38986412 | ||
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
Protective and Harmful Immunity to RSV Infection. | Q39146784 | ||
Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny | Q39193871 | ||
Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. | Q39256577 | ||
Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection | Q39485087 | ||
Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells | Q39495155 | ||
Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. | Q39803969 | ||
TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide | Q40117878 | ||
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells | Q40140592 | ||
Exposure to Bacterial CpG DNA Protects from Airway Allergic Inflammation by Expanding Regulatory Lung Interstitial Macrophages. | Q40283385 | ||
Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity | Q40321692 | ||
Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates | Q40432390 | ||
Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. | Q40475481 | ||
P304 | page(s) | 1570 | |
P577 | publication date | 2017-11-14 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Innate Immunity to Respiratory Infection in Early Life | |
P478 | volume | 8 |
Q100431442 | Abnormalities of ILC1 in children with hand, foot and mouth disease during enterovirus 71 infection |
Q90474748 | First Pediatric Case of Coronavirus Disease 2019 in Korea |
Q64247644 | Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections |
Q91711990 | Infant Alveolar Macrophages Are Unable to Effectively Contain Mycobacterium tuberculosis |
Q90697417 | Innate Immune Evasion by Human Respiratory RNA Viruses |
Q60922609 | Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010 |
Q96640266 | R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice |
Search more.